BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 28851903)

  • 21. Prion protein (PrP) knock-out mice show altered iron metabolism: a functional role for PrP in iron uptake and transport.
    Singh A; Kong Q; Luo X; Petersen RB; Meyerson H; Singh N
    PLoS One; 2009 Jul; 4(7):e6115. PubMed ID: 19568430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The retention of prion protein in the endoplasmic reticulum prevents N2A cells from proteasome inhibition-induced cytotoxicity.
    Fang S; Wang R; Liu H; Zhuang W; Wang Z; Zhang J; Pei L; Liu Y; Su Y
    Biochem Biophys Res Commun; 2017 Sep; 491(2):500-507. PubMed ID: 28669732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of GPI-anchored PrP C in mediating the neurotoxic effect of scrapie prions in neurons.
    Radford HE; Mallucci GR
    Curr Issues Mol Biol; 2010; 12(2):119-27. PubMed ID: 19767655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The protease-sensitive N-terminal polybasic region of prion protein modulates its conversion to the pathogenic prion conformer.
    Zhang X; Pan YH; Chen Y; Pan C; Ma J; Yuan C; Yu G; Ma J
    J Biol Chem; 2021 Nov; 297(5):101344. PubMed ID: 34710372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-synuclein modulates retinal iron homeostasis by facilitating the uptake of transferrin-bound iron: Implications for visual manifestations of Parkinson's disease.
    Baksi S; Tripathi AK; Singh N
    Free Radic Biol Med; 2016 Aug; 97():292-306. PubMed ID: 27343690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mechanisms of prion transmission].
    Sakaguchi S
    Nihon Rinsho; 2007 Aug; 65(8):1391-5. PubMed ID: 17695274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Copper binding to PrPC may inhibit prion disease propagation.
    Hijazi N; Shaked Y; Rosenmann H; Ben-Hur T; Gabizon R
    Brain Res; 2003 Dec; 993(1-2):192-200. PubMed ID: 14642846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prion protein conversion induced by trivalent iron in vesicular trafficking.
    Choi BR; Lee J; Kim SY; Yim I; Kim EH; Woo HJ
    Biochem Biophys Res Commun; 2013 Mar; 432(3):539-44. PubMed ID: 23416082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trapping prion protein in the endoplasmic reticulum impairs PrPC maturation and prevents PrPSc accumulation.
    Cardinale A; Filesi I; Vetrugno V; Pocchiari M; Sy MS; Biocca S
    J Biol Chem; 2005 Jan; 280(1):685-94. PubMed ID: 15513919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temporal Resolution of Misfolded Prion Protein Transport, Accumulation, Glial Activation, and Neuronal Death in the Retinas of Mice Inoculated with Scrapie.
    West Greenlee MH; Lind M; Kokemuller R; Mammadova N; Kondru N; Manne S; Smith J; Kanthasamy A; Greenlee J
    Am J Pathol; 2016 Sep; 186(9):2302-9. PubMed ID: 27521336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Critical significance of the region between Helix 1 and 2 for efficient dominant-negative inhibition by conversion-incompetent prion protein.
    Taguchi Y; Mistica AM; Kitamoto T; Schätzl HM
    PLoS Pathog; 2013; 9(6):e1003466. PubMed ID: 23825952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prion protein regulates iron transport by functioning as a ferrireductase.
    Singh A; Haldar S; Horback K; Tom C; Zhou L; Meyerson H; Singh N
    J Alzheimers Dis; 2013; 35(3):541-52. PubMed ID: 23478311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crossing Species Barriers Relies on Structurally Distinct Prion Assemblies and Their Complementation.
    Igel-Egalon A; Laferrière F; Tixador P; Moudjou M; Herzog L; Reine F; Torres JM; Laude H; Rezaei H; Béringue V
    Mol Neurobiol; 2020 Jun; 57(6):2572-2587. PubMed ID: 32239450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prion protein and metal interaction: physiological and pathological implications.
    Singh N; Das D; Singh A; Mohan ML
    Curr Issues Mol Biol; 2010; 12(2):99-107. PubMed ID: 19767653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discriminating between cellular and misfolded prion protein by using affinity to 9-aminoacridine compounds.
    Phuan PW; Zorn JA; Safar J; Giles K; Prusiner SB; Cohen FE; May BCH
    J Gen Virol; 2007 Apr; 88(Pt 4):1392-1401. PubMed ID: 17374787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sheep scrapie susceptibility-linked polymorphisms do not modulate the initial binding of cellular to disease-associated prion protein prior to conversion.
    Rigter A; Bossers A
    J Gen Virol; 2005 Sep; 86(Pt 9):2627-2634. PubMed ID: 16099922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Manganese upregulates cellular prion protein and contributes to altered stabilization and proteolysis: relevance to role of metals in pathogenesis of prion disease.
    Choi CJ; Anantharam V; Martin DP; Nicholson EM; Richt JA; Kanthasamy A; Kanthasamy AG
    Toxicol Sci; 2010 Jun; 115(2):535-46. PubMed ID: 20176619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoacylated cellular prion protein modifies cell membranes, inhibits cell signaling, and reduces prion formation.
    Bate C; Williams A
    J Biol Chem; 2011 Mar; 286(11):8752-8. PubMed ID: 21212283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
    Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
    Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue plasminogen activator in brain tissues infected with transmissible spongiform encephalopathies.
    Xanthopoulos K; Paspaltsis I; Apostolidou V; Petrakis S; Siao CJ; Kalpatsanidis A; Grigoriadis N; Tsaftaris A; Tsirka SE; Sklaviadis T
    Neurobiol Dis; 2005 Nov; 20(2):519-27. PubMed ID: 15922607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.